Respiratory

A study looks at whether a vaccine for respiratory syncytial virus (RSV) could be effective in reducing RSV-associated, medically significant lower respiratory tract infections in infants.

Animal studies have shown bisphenol A (BPA) has an impact on asthma morbidity. A new human study offers some further information.

A recent report emphasizes the work of primary care physicians in preventing tobacco use in teens, noting that prevention is the best tool to combat smoking initiation.

Children who at first did not appear to contract COVID-19 have been found to exhibit a more serious illness that has now been reported worldwide. Two experts offer guidance on recognizing and treating multisystem inflammatory syndrome in children (MIS-C).

Scheduled follow-up following hospitalization for bronchiolitis is typical care, but a new report questions whether as-needed care can be just as effective.

The location where care is received can impact how medication is prescribed. A report examines how location impacts care for pneumonia and sinusitis.

Marketing for traditional cigarettes has long been curtailed to stem smoking, but the regulations haven’t always caught up with the marketing needs for vaping. A report examines the impact of promoting vaping on the prevalence of vaping.

For many children, a furry animal can be a best friend. An investigation looks at whether that bond can also protect against asthma and allergies.

For children with asthma, exposure to dog allergens could exacerbate outcomes.

Respiratory syncytial virus (RSV) is a major cause of hospitalized acute respiratory illness in young children. An investigation looks at the hospitalization burden due to RSV.

Persistent patent ductus arteriosus is tied to increased mortality and many respiratory mortalities. A report compares treatment with ibuprofen versus no intervention.

A new study connects an asthma diagnosis to type 1 diabetes (T1D) development later in life but also shows that the opposite may not be true.

Although the majority of patients with cystic fibrosis (CF) will be managed by specialty care, the primary care provider is often the first line of contact for many routine concerns. When encountering a patient with CF in the primary setting, there are extrapulmonary symptoms that must be considered in patients, which includes gastrointestinal symptoms.

Significant improvements in cystic fibrosis (CF) care have focused primarily on the pulmonary system, but addressing the gastrointestinal complications of CF presents a major opportunity for improvement in disease management.

Treatments for cystic fibrosis are evolving. Here’s a look at new CFTR modulator therapies including the most recent approval-elexacaftor/tezacaftor/ivacaftor (Trikafta).

Pediatricians need to implement the strategies of assessing, adjusting, and reviewing symptoms and risks of severe asthma to confirm the diagnosis and implement appropriate interventions.

Using palivizumab in infants with cystic fibrosis (CF) may not lead to long-term improvements, according to a new study published in Pediatrics. Researchers used the Cystic Fibrosis Foundation Patient Registry data.

Certainly, these are interesting times in medicine as the integration of homeopathic remedies and over-the-counter supplements has become increasingly more common in the past few decades. However, with inconsistent medical research and a lack of US Food and Drug Administration regulation, it remains unclear what the most safe and efficacious role these substances will play in the future of medical care.

Severe or refractory asthma places a small subset of children with asthma at risk for significant morbidity and treatment challenges, as well as for higher healthcare utilization and costs.

Patients with cystic fibrosis (CF) are deficient in vitamin D, which at higher levels can help prevent exacerbation. A new study examines current guidelines and future recommendations.

Tailoring drug delivery modalities to the individual patient based on age, ability level, and preference can optimize control of pediatric asthma.

Asking a series of questions that can lead to more appropriate preventive medication use can go a long way in improving the health of children with asthma and reduce hospitalizations.

Wheezing in children is often associated with asthma. However, localized wheezing should alert the clinician that something other than asthma may be present.

For Contemporary Pediatrics, Dr Bobby Lazzara discusses a recent prospective birth cohort study published in Pediatrics that looked at different feeding methods for infants and whether the methods had any link to asthma.

Respiratory symptoms are a major reason why outpatients seek medical care, and primary care physicians who treat children frequently see pneumonia. This week’s photo essay tests your knowledge of respiratory problems in kids.

Although bronchiolitis is commonly seen in very young children, the infection can be dangerous and even fatal for some infants. Here, new thoughts on risk factors that may determine which babies get very sick.

Hoarseness developed in a 27-month-old girl who was previously treated in the ED for a presumed asthma exacerbation and bronchiolitis.

A 6-month-old boy with 1-week history of dry cough that worsened at night. He had been wheezing off and on for the past month and had visited the emergency department on one occasion.